Nathan Steven Anderson, MD
Cardiovascular Disease (Cardiology) · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 19 years
- Graduated 2007
Offices
1 location · Providence Medical Foundation · 1,461 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Mendocino Coast · Adventist Health Ukiah Valley · Healdsburg Hospital · Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Anderson’s office at (707) 303-8330 to ask if they take your plan before you enroll.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Healdsburg HospitalHealdsburg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Providence, which runs 54 hospitals in 7 states77% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Healdsburg Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 45 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 109 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.8 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 84% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$165,473
Medicare paid this office $165,473 for 1,238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 366 | $51,677 | $101 |
| New patient visit (45+ min) | 210 | $25,586 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $15,813 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $9,218 | $55 |
| Long return visit (40+ min) | 41 | $6,238 | $139 |
See all 27 services
| Return visit (30+ min) | 366 | $51,677 | $101 |
| New patient visit (45+ min) | 210 | $25,586 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $15,813 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $9,218 | $55 |
| Long return visit (40+ min) | 41 | $6,238 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $5,511 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $4,584 | $65 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 280 | $4,406 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $4,347 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 545 | $3,799 | $6 |
| New patient visit (60+ min) | 23 | $3,764 | $164 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 51 | $2,891 | $57 |
| Programming of dual lead pacemaker system | 31 | $2,560 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,551 | $142 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,153 | $86 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,425 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,412 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 108 | $1,203 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $985 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 26 | $520 | $19 |
| Ultrasound of heart, follow-up | 20 | $384 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $296 | $10 |
| Heart rhythm recording of continous external ekg over 8-15 days | 27 | $296 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $174 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $155 | $10 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $149 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $60 | $2 |
Who their Medicare patients are
1,238 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 21% · Women 50% · Also on Medicaid 30% · Health risk score 1.78. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 42% · Atrial fibrillation 40% · Heart failure 37% · Chronic kidney disease 33% · Diabetes 32% · Depression 28% · COPD 25% · Cancer 19% · Stroke 16% · Dementia 12%.
The office billed $711,165, Medicare allowed $226,006 and paid $165,473; for 2,984 services of 60 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,238 | 2,984 | 77 | 1.78 | $711,165 | $165,473 |
| 2023 | 1,937 | 3,204 | 76 | 1.43 | $565,717 | $144,803 |
| 2022 | 2,065 | 3,367 | 75 | 1.37 | $471,295 | $127,932 |
| 2021 | 1,789 | 3,040 | 75 | 1.37 | $403,806 | $119,351 |
| 2020 | 786 | 1,226 | 74 | 1.28 | $189,327 | $61,874 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 258 | $26,386 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 484 | $25,228 | $51 |
| New patient visit (45+ min) | 126 | $16,827 | $134 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $9,991 | $167 |
| New patient visit (60+ min) | 44 | $7,545 | $171 |
| Long return visit (40+ min) | 50 | $7,355 | $147 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 123 | $7,161 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $6,095 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 746 | $5,423 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,010 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,711 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 223 | $2,434 | $11 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,291 | $143 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,163 | $87 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 46 | $2,116 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 180 | $1,885 | $10 |
| New patient visit (30+ min) | 20 | $1,666 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,334 | $74 |
| Ultrasound of heart, follow-up | 64 | $1,230 | $19 |
| Short return visit (20+ min) | 15 | $971 | $65 |
| Programming of dual lead pacemaker system | 18 | $711 | $37 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $581 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 51 | $282 | $5 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $254 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 92 | $212 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $65 | $5 |
2022: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 666 | $34,738 | $51 |
| Return visit (30+ min) | 255 | $26,397 | $92 |
| New patient visit (45+ min) | 119 | $14,147 | $119 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 255 | $14,038 | $55 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 92 | $4,747 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 345 | $3,680 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 530 | $3,612 | $6 |
| Short return visit (20+ min) | 43 | $2,886 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $2,809 | $83 |
| Ultrasound of heart with probe in esophagus, with report | 28 | $2,401 | $83 |
| Ultrasound of heart, follow-up | 104 | $2,049 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 117 | $1,622 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $1,530 | $118 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 137 | $1,352 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,347 | $56 |
| New patient visit (30+ min) | 13 | $1,007 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $865 | $72 |
| Programming of dual lead pacemaker system | 16 | $647 | $31 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 86 | $482 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 189 | $456 | $2 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 11 | $219 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $151 | $6 |
2021: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 585 | $30,249 | $51 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 275 | $15,567 | $56 |
| New patient visit (45+ min) | 110 | $14,426 | $131 |
| Return visit (30+ min) | 115 | $13,513 | $95 |
| Telephone medical discussion with physician, 21-30 minutes | 73 | $6,761 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $5,897 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 420 | $4,669 | $11 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 80 | $3,975 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 504 | $3,763 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,201 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $3,137 | $83 |
| Ultrasound of heart, follow-up | 92 | $1,874 | $19 |
| New patient visit (30+ min) | 20 | $1,841 | $92 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $1,834 | $83 |
| Short return visit (20+ min) | 21 | $1,559 | $71 |
| Ultrasound of heart blood flow, valves and chambers | 98 | $1,306 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 68 | $393 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 163 | $384 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $372 | $12 |
2020: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 315 | $18,115 | $57 |
| New patient visit (45+ min) | 55 | $6,879 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $5,580 | $159 |
| Return visit (30+ min) | 53 | $4,679 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $4,504 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 59 | $3,821 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 55 | $3,091 | $56 |
| New patient visit (30+ min) | 29 | $2,498 | $86 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 163 | $2,016 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,048 | $62 |
| Ultrasound of heart, follow-up | 48 | $1,041 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 63 | $926 | $15 |
| Programming of dual lead pacemaker system | 21 | $539 | $26 |
| Programming of multiple lead implantable defibrillator system | 13 | $356 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 95 | $242 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 31 | $191 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $84 | $7 |
Medicaid work
$29,860 in 2024
Medicaid paid $29,860 for 849 billed services this clinician did in 2024, up to 105 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 92 | $9,447 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 462 | $6,787 |
| Return visit (30+ min) | 174 | $6,579 |
| New patient visit (45+ min) | 87 | $6,205 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 34 | $842 |
| 2024 | 849 | 5 | 105 | $29,860 |
| 2023 | 840 | 5 | 87 | $26,878 |
| 2022 | 486 | 4 | 64 | $12,504 |
| 2021 | 377 | 2 | 67 | $7,511 |
| 2020 | 84 | 1 | 19 | $3,660 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 188 | $12,991 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 473 | $6,447 |
| New patient visit (45+ min) | 70 | $4,982 |
| Return visit (30+ min) | 53 | $1,232 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 56 | $1,226 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 178 | $9,860 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 281 | $1,943 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $560 |
| CARDIOVASCULAR STRESS TEST | 15 | $141 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 104 | $5,479 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 273 | $2,031 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 84 | $3,660 |
Drugs they prescribed that Part D paid
$570,854
Pharmacies billed $570,854 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,959) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,492 generic and 467 brand-name prescriptions · $570,854 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 205 | $254,247 | $1,240 |
| Jardiance | 88 | $122,430 | $1,391 |
| Entresto | 38 | $46,362 | $1,220 |
| Repatha Sureclick | 31 | $34,150 | $1,102 |
| Xarelto | 27 | $30,578 | $1,133 |
See all 33 drugs
| Eliquis | 205 | $254,247 | $1,240 |
| Jardiance | 88 | $122,430 | $1,391 |
| Entresto | 38 | $46,362 | $1,220 |
| Repatha Sureclick | 31 | $34,150 | $1,102 |
| Xarelto | 27 | $30,578 | $1,133 |
| Ezetimibe | 105 | $3,336 | $32 |
| Atorvastatin | 326 | $3,091 | $9 |
| Amiodarone | 27 | $3,058 | $113 |
| Ranolazine Er | 17 | $2,258 | $133 |
| Metoprolol | 115 | $2,060 | $18 |
| Telmisartan | 59 | $1,865 | $32 |
| Rosuvastatin | 64 | $1,516 | $24 |
| Nitroglycerin | 17 | $1,119 | $66 |
| Spironolactone | 86 | $981 | $11 |
| Diltiazem 24hr Er | 16 | $954 | $60 |
| Flecainide Acetate | 15 | $879 | $59 |
| Metoprolol | 92 | $841 | $9 |
| Eplerenone | 12 | $829 | $69 |
| Losartan | 44 | $709 | $16 |
| Carvedilol | 70 | $663 | $9 |
| Diltiazem 24hr Er (Cd) | 13 | $641 | $49 |
| Furosemide | 53 | $544 | $10 |
| Verapamil Er | 22 | $462 | $21 |
| Lisinopril | 51 | $344 | $7 |
| Clopidogrel | 25 | $296 | $12 |
| Amlodipine Besylate | 53 | $294 | $6 |
| Benazepril | 11 | $284 | $26 |
| Torsemide | 17 | $262 | $15 |
| Metformin | 13 | $158 | $12 |
| Isosorbide Mononitrate Er | 19 | $142 | $7 |
| Ramipril | 15 | $114 | $8 |
| Warfarin | 23 | $88 | $4 |
| Hydrochlorothiazide | 13 | $69 | $5 |
Year by year
| 2024 | 1,959 | 498 | 0% (0) | 24% | $570,854 |
| 2023 | 1,907 | 436 | 0% (0) | 19% | $498,559 |
| 2022 | 1,835 | 320 | 0% (0) | 20% | $400,579 |
| 2021 | 933 | 192 | 0% (0) | 28% | $207,407 |
| 2020 | 213 | 75 | 0% (0) | 27% | $46,152 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Eliquis | 161 | $198,950 | $1,236 |
| Jardiance | 107 | $141,259 | $1,320 |
| Entresto | 20 | $32,053 | $1,603 |
| Xarelto | 23 | $29,588 | $1,286 |
| Repatha Sureclick | 16 | $17,324 | $1,083 |
| Nexletol | 12 | $15,286 | $1,274 |
| Atorvastatin | 237 | $3,368 | $14 |
| Metoprolol | 160 | $3,250 | $20 |
| Diltiazem 12hr Er | 12 | $2,357 | $196 |
| Ezetimibe | 46 | $1,954 | $42 |
| Rosuvastatin | 63 | $1,883 | $30 |
| Losartan | 140 | $1,806 | $13 |
| Amiodarone | 12 | $1,653 | $138 |
| Isosorbide Mononitrate Er | 31 | $1,284 | $41 |
| Carvedilol | 122 | $1,239 | $10 |
| Spironolactone | 139 | $1,119 | $8 |
| Potassium Chloride | 46 | $1,116 | $24 |
| Lisinopril | 98 | $1,104 | $11 |
| Flecainide Acetate | 11 | $985 | $90 |
| Telmisartan | 14 | $928 | $66 |
| Diltiazem 24hr Er (Cd) | 20 | $818 | $41 |
| Nitroglycerin | 13 | $762 | $59 |
| Torsemide | 25 | $729 | $29 |
| Bumetanide | 13 | $559 | $43 |
| Metoprolol | 61 | $555 | $9 |
| Amlodipine Besylate | 56 | $386 | $7 |
| Digoxin | 20 | $299 | $15 |
| Furosemide | 39 | $238 | $6 |
| Clopidogrel | 18 | $184 | $10 |
| Simvastatin | 13 | $139 | $11 |
| Hydrochlorothiazide | 15 | $116 | $8 |
| Warfarin | 11 | $37 | $3 |
2022: 29 drugs
| Eliquis | 163 | $174,153 | $1,068 |
| Jardiance | 71 | $69,584 | $980 |
| Xarelto | 50 | $56,770 | $1,135 |
| Entresto | 23 | $28,376 | $1,234 |
| Multaq | 11 | $10,058 | $914 |
| Repatha Sureclick | 15 | $8,617 | $574 |
| Metoprolol | 149 | $3,053 | $20 |
| Diltiazem 12hr Er | 11 | $2,437 | $222 |
| Atorvastatin | 190 | $2,192 | $12 |
| Rosuvastatin | 64 | $1,665 | $26 |
| Losartan | 104 | $1,432 | $14 |
| Spironolactone | 152 | $1,428 | $9 |
| Carvedilol | 136 | $1,422 | $10 |
| Flecainide Acetate | 15 | $1,270 | $85 |
| Potassium Chloride | 38 | $762 | $20 |
| Isosorbide Mononitrate Er | 40 | $738 | $18 |
| Torsemide | 21 | $738 | $35 |
| Telmisartan | 16 | $706 | $44 |
| Ranolazine Er | 12 | $677 | $56 |
| Ezetimibe | 25 | $647 | $26 |
| Nitroglycerin | 24 | $640 | $27 |
| Lisinopril | 94 | $611 | $7 |
| Amlodipine Besylate | 63 | $576 | $9 |
| Diltiazem 24hr Er (Cd) | 17 | $516 | $30 |
| Furosemide | 52 | $382 | $7 |
| Metoprolol | 40 | $324 | $8 |
| Digoxin | 17 | $237 | $14 |
| Clopidogrel | 26 | $233 | $9 |
| Hydrochlorothiazide | 30 | $213 | $7 |
2021: 24 drugs
| Eliquis | 110 | $93,510 | $850 |
| Xarelto | 22 | $24,458 | $1,112 |
| Entresto | 18 | $17,363 | $965 |
| Multaq | 13 | $10,839 | $834 |
| Jardiance | 18 | $9,782 | $543 |
| Praluent | 14 | $9,585 | $685 |
| Repatha Sureclick | 11 | $5,968 | $543 |
| Metoprolol | 88 | $1,858 | $21 |
| Ranolazine Er | 16 | $1,755 | $110 |
| Atorvastatin | 111 | $1,685 | $15 |
| Flecainide Acetate | 12 | $1,338 | $111 |
| Ezetimibe | 12 | $739 | $62 |
| Rosuvastatin | 19 | $716 | $38 |
| Lisinopril | 66 | $520 | $8 |
| Carvedilol | 47 | $514 | $11 |
| Spironolactone | 48 | $431 | $9 |
| Furosemide | 40 | $408 | $10 |
| Amlodipine Besylate | 35 | $384 | $11 |
| Nitroglycerin | 14 | $279 | $20 |
| Losartan | 32 | $277 | $9 |
| Clopidogrel | 15 | $162 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $132 | $12 |
| Metoprolol | 21 | $101 | $5 |
| Hydrochlorothiazide | 14 | $83 | $6 |
2020: 5 drugs
| Eliquis | 29 | $23,465 | $809 |
| Ranolazine Er | 11 | $677 | $62 |
| Metoprolol | 18 | $457 | $25 |
| Atorvastatin | 23 | $321 | $14 |
| Lisinopril | 22 | $136 | $6 |
Money from drug and device companies
$487 in 2025
| 2025 | 8 | 16 | None | $487 |
| 2024 | 4 | 8 | None | $141 |
| 2023 | 5 | 10 | None | $222 |
| 2022 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Flx | $256 | 6 payments
|
| Abbott Laboratories | Cardiomems | $103 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $32 | 1 payment
|
| Heartflow | Ffrct | $31 | 1 payment
|
| Alnylam Pharmaceuticals | Amvuttra | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Wainua | $17 | 1 payment
|
See all 16 published payments
| Boston Scientific | Meals · 2025-12-19 | Watchman Flx | $87 |
| Abbott Laboratories | Meals · 2025-12-09 | Cardiomems | $24 |
| Abbott Laboratories | Meals · 2025-10-31 | Cardiomems | $26 |
| Boston Scientific | Meals · 2025-10-27 | Watchman Flx | $52 |
| Abbott Laboratories | Meals · 2025-10-13 | 2nd Gen Centrimag Primary Console | $26 |
| Heartflow | Meals · 2025-09-25 | Ffrct | $31 |
| Alnylam Pharmaceuticals | Meals · 2025-09-09 | Amvuttra | $20 |
| Boston Scientific | Meals · 2025-07-21 | Watchman Flx | $47 |
| Boston Scientific | Meals · 2025-07-10 | Farapulse | $11 |
| Boston Scientific | Meals · 2025-05-01 | Watchman Flx | $52 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-08 | Wainua | $17 |
| Boston Scientific | Meals · 2025-02-06 | Watchman Flx | $7 |
| Esperion Therapeutics | Meals · 2025-01-23 | Nexletol | $14 |
| Amgen | Meals · 2025-01-21 | Repatha | $14 |
| Abbott Laboratories | Meals · 2025-01-20 | Triclip | $28 |
| Actelion Pharmaceuticals US | Meals · 2025-01-14 | Uptravi | $32 |
See earlier years (2024, 2023, 2022)
2024: $141
| Amgen | Repatha | $56 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $44 | 3 payments
|
| Lexicon Pharmaceuticals | None | $23 | 1 payment
|
| Medtronic | Linq II | $17 | 1 payment
|
2023: $222
| E.R. Squibb & Sons L.L.C. | Camzyos | $71 | 3 payments
|
| Esperion Therapeutics | Nexletol | $51 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $46 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $34 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $20 | 1 payment
|
2022: $18
| Abbott Laboratories | Proclaim | $18 | 1 payment
|
Professional record
- NPI
- 1861698656
- Licence
- MT MED-PHYS-LIC-81009, VA 0101245111
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- Po Box 12, Liberty Lake, WA, 99019
- NPI first listed
- 2007-06-27
- NPI last updated
- 2020-04-15
- NPI record certified
- 2020-04-15
This is when the NPI record was last certified, not a medical board exam.